Bayesian Joint Modeling for Disease Progression Prediction

Published:Dec 29, 2025 17:36
1 min read
ArXiv

Analysis

This paper addresses a critical problem in medical research: accurately predicting disease progression by jointly modeling longitudinal biomarker data and time-to-event outcomes. The Bayesian approach offers advantages over traditional methods by accounting for the interdependence of these data types, handling missing data, and providing uncertainty quantification. The focus on predictive evaluation and clinical interpretability is particularly valuable for practical application in personalized medicine.

Reference

The Bayesian joint model consistently outperforms conventional two-stage approaches in terms of parameter estimation accuracy and predictive performance.